Health Catalyst, Inc.HCATNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-0.90%
↓ 149% below average
Average (30q)
1.82%
Historical baseline
Range
High:38.80%
Low:-26.70%
Volatility
3589.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -0.90% |
| Q2 2025 | -18.40% |
| Q1 2025 | 1.23% |
| Q4 2024 | 5.70% |
| Q3 2024 | 2.23% |
| Q2 2024 | -6.64% |
| Q1 2024 | -26.70% |
| Q4 2023 | 14.84% |
| Q3 2023 | 0.44% |
| Q2 2023 | 2.97% |
| Q1 2023 | -12.91% |
| Q4 2022 | -5.57% |
| Q3 2022 | 14.45% |
| Q2 2022 | 5.83% |
| Q1 2022 | -1.89% |
| Q4 2021 | 6.68% |
| Q3 2021 | 12.81% |
| Q2 2021 | 1.25% |
| Q1 2021 | -4.23% |
| Q4 2020 | 11.86% |
| Q3 2020 | 11.02% |
| Q2 2020 | -7.85% |
| Q1 2020 | 0.35% |
| Q4 2019 | -3.22% |
| Q3 2019 | 38.80% |
| Q2 2019 | -3.11% |
| Q1 2019 | -5.10% |
| Q4 2018 | -2.56% |
| Q3 2018 | 27.71% |
| Q2 2018 | -2.50% |
| Q1 2018 | 0.00% |